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Argon exposure during reperfusion: impact on myocardial remodeling and 
reperfusion arrhythmias
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Abraini (2), Denis Agostini (3), Paul Milliez (1), Alain Manrique (2) 
(1) CHU de Caen, cardiologie, Caen, France – (2) Normandie Université, 
EA4650, Caen, France – (3) CHU Caen, médecine nucléaire, Caen, France
Objectives: Preconditioning with noble gases protects myocardium against 
reperfusion injury. We aimed to evaluate the postconditioning effect of argon on 
myocardial remodeling and arrhythmias.
Methods: 30 wistar rats, instrumented for cardiac monitoring, were subjected 
to ischemia and reperfusion, then separated into 3 groups: a control group (C, n=8), 
a group subjected to ischemic postconditioning (IPC, n=9) and a group with argon 
postconditioning (APC, n=13, rats received a mixture of argon (70%) and oxygen 
(30%) for 20 min, started 5 min before reperfusion). Cardiac MR was performed at 
1 (W1) and 3 weeks (W3) to assess LV function, edema and strain. FDG PET was 
acquired at W3 to assess myocardial viability and glucose metabolism (Ki).
Results: At W1, LVEF was preserved in IPC (56%±6) compared to C (43%±10, 
p=0.02) and the number of normokinetic segments was higher in IPC (13.4±1.9 vs 
10.6±2.2 in C, p=0.02).
At W3, the number of normokinetic segments was signifi cantly higher in both 
IPC (14.4±2.2) and APC (13.7±1.8) vs C (12.1±1.8, p=0.04 and p<0.05). Wall 
Motion Score decreased from W1 to W3 in APC (1.4±0.2 vs 1.3±0.2, p=0.005) and 
IPC (1.3±0.2 vs 1.2±0.2, p<0.05), remaining increased in C (1.4±0.2) vs both APC 
(p<0.05) and IPC (p=0.03). Circumferential strain improved in APC (p<0.02) and 
worsened in C (p=0.02).
IPC but not APC improved fractional wall thickening (p=0.008) and decreased 
myocardial edema (p=0.02). The number of non-viable segments was decreased in 
IPC (0.7±1.4) vs C (3.4±2.1, p=0.03) and APC (3±2.5, p=0.02). IPC enhanced glucose 
metabolism (Ki) compared to APC (p<0.0001) and C (p=0.006).
Heart rate decreased during reperfusion in IPC (223±72 vs 302±40, p=0.027) 
and APC (242±43 vs 304±41, p=0.005). Ventricular arrhythmias were less frequent 
in PCA (0 vs 5, Chi2: 4.59, p=0.03).
Conclusions: APC improved regional contraction and protected from reperfusio 
arrhythmias. The impact of argon exposure did not limit infarct size or cardiac 
remodeling.
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Intermittent Hypoxia is associated with a high risk of AMI-related ventricular 
arrhythmias 
Claire Arnaud, Vincent Venchiarutti, Diane Godin-Ribuot
Laboratoire HP2 – Inserm U1042, Grenoble, France
Rationale: Acute myocardial infarction (AMI) -induced ventricular arrhythmias 
are a common cause of sudden cardiac death. Among arrhythmogenic mechanisms, 
increased activity of the sympathetic nervous system is well known to predispose to 
AMI-related ventricular arrhythmias. Obstructive sleep apnea (OSA) causes chronic 
intermittent hypoxia (IH) that leads to an increase in sympathetic activity along with 
endothelial dysfunction and myocardial damage. 
Objectives: The aim of this study was to investigate whether rats exposed to 
chronic IH had an increased probability to develop AMI-induced ventricular arrhythmias. 
Methods: 60 male Wistar rats were exposed to IH (60-sec cycles alternating 21 
and 5% FiO2 during 8h/day) or intermittent air for 14 days. They were then submitted 
to an in vivo myocardial ischemia (30 min) -reperfusion (120 min) protocol by ligature 
of the left coronary artery. Arterial blood pressure was measured and ECG was recorded 
throughout the experiment in order to analyze cardiac arrhythmias.
Results: Mean arterial blood pressure was signifi cantly increased in hypoxic 
compared to normoxic rats (138.4±3.4 vs 113.2±2.6 mmHg respectively, p<0.05). 
Rats exposed to IH were also more susceptible to AMI-induced arrhythmias. The most 
frequent arrhythmia was ischemia-induced ventricular fi brillation, which occurred 
around the 7th min of ischemia in 7 out of 27 (25.9%) of normoxic vs 13 out of 23 
(56.5%) hypoxic rats (p<0.05). Plasma catecholamine concentrations are currently 
under analysis but preliminary data in isolated hearts show a signifi cantly increased 
release of noradrenaline in the coronary effl uent upon ischemia in hypoxic rats.
Conclusion: Intermittent hypoxia, a major component of OSA syndrome, increases 
AMI-induced lethal ventricular arrhythmias in rats, probably through sympathoactivation. 
Cardiac arrhythmias are common during sleep in OSA patients but this study suggests 
an increased risk of lethal arrhythmias in those presenting with AMI.
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Postconditioning attenuates no refl ow in STEMI patients 
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Background: After acute myocardial infarction, the presence of no-refl ow (or 
microvascular obstruction: MVO) has been associated with adverse LV remodeling 
and worse clinical outcome. This study examined the effects of mechanical ischemic 
postconditioning on early and late MVO size in acute ST-elevation myocardial 
infarction (STEMI) patients. 
Methods and Results: Fifty patients undergoing primary coronary angioplasty for 
a fi rst STEMI with TIMI grade fl ow 0-1 and no collaterals were randomized to ischemic 
postconditioning (PC) (n=25) or control (n=25) groups. Ischemic PC consisted in the 
application of four consecutive cycles of a 1-minute balloon occlusion, each followed by 
a 1-minute defl ation at the onset of reperfusion. Early (3 minutes post-contrast) and late 
(10 minutes post-contrast) MVO size was assessed by contrast-enhanced cardiac-MRI 72 
hours after reperfusion. 
PC was associated with smaller early and late MVO size (5.1±6.7g in PC vs 
11.3±11.0 g in controls for early MVO; p=0.02; and 2.5±4.6 g in PC versus 5.9±6.1 
g in controls for late MVO; p=0.03). This signifi cant reduction was persistent after 
adjustment for thrombus aspiration, which did not have any signifi cant effect on 
infarct size, nor early or late MVO (p=0.23; p=0.99 and p=0.64). Attenuation of MVO 
appeared to be partly due to the infarct size reduction, but also to result from a direct 
effect of PC on the coronary microvasculature. 
Conclusion: Mechanical postconditioning signifi cantly reduces MVO in patients 
with acute STEMI treated with primary angioplasty. 
097
Does pre-PCI angiographic TIMI fl ow in the culprit coronary artery infl uence 
infarct size and microvascular obstruction in acute STEMI patients?
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Eric Bonnefoy-Cudraz (1), Ingrid Sanchez (1), Cyrille Bergerot (1), Helene 
Thibault (1), Gerard Finet (1), Didier Revel (1), Christophe Piot (2), Claire 
Jossan (1), Inesse Sahraoui (1), Pierre Croisille (1), Michel Ovize (1) 
(1) Hôpital Louis Pradel, centre d’investigation clinique, Bron, France – (2) CHU 
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Background: The infl uence of pre-treatment initial coronary fl ow in the culprit 
coronary artery on myocardial infarct size and microvascular obstruction (MVO) is 
unclear.
Aims: To compare the impact of pre-PCI occlusion of the culprit coronary artery 
versus non-occlusion on infarct size, MVO incidence and size by MRI.
Methods: In a prospective multicenter study in acute ST-elevated myocardial 
infarction patients, Pre-PCI culprit coronary occlusion was defi ned by an initial TIMI 
fl ow ≤1 and absence of occlusion was defi ned by an initial TIMI fl ow ≥2. Infart size 
and microvascular obstruction presence and size were measured on ce-CMR 48 to 
72 hours after PCI study.
Results: 143 patients, age 58±12 years, 83% males, with culprit coronary occlusion in 
62 (43%) and non-occlusion in 81 (56%) were included. There was no signifi cant difference 
in fi nal post-PCI TIMI fl ow between groups (2.95±0.02 vs 2.97±0.02 respectively; 
p=0.44). There were no signifi cant baseline demographic differences between groups. 
Compared to non-occluded group, the occluded group was treated signifi cantly more 
often with thrombus aspiration (66% vs 32% respectively, p=0.005) and less often 
with pre-hospital thienopyridine use (2% received prasugrel versus 25%; p<0.0001). 
There were no differences between groups in aspirin and GPIIbIIIa inhibitors 
treatment neither in ischemic time between groups (279±217 minutes VS 250±182 
minutes respectively, p=0.40).
In the occluded group (compared to the non-occluded group): Infarct size was 
signifi cantly larger (31±17 grams vs 20±16 grams respectively, p=0.001), incidence 
of MVO was signifi cantly higher (69% VS 40% respectively; p=0.004) as well as 
there was a non-signifi cant trend toward greater MVO size (4±6 grams vs 2±5 grams 
respectively, p=0.026) (fi gure 1).
Conclusions: Initial angiographic TIMI fl ow in the culprit coronary artery prior 
to any PCI could predict both fi nal infarct size and MVO: the better the TIMI fl ow 
(that is the higher), the smaller the infarct size and MVO size.
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Figure – Abstract 097 – Infarct size and MVO size versus Pre-PCI TIMI
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ischemia-reperfusion injury is well recognized. We questioned here whether the 
transfer of Ca2+ from ER to mitochondria might play a role in cardiomyocyte death 
after hypoxia-reoxygenation.
Methods and results: We report that CypD interacts with the VDAC1/
Grp75/IP3R1 complex in cardiomyocytes. Genetic or pharmacologic inhibition 
of CypD in both H9c2 cardiomyoblasts and adult cardiomyocytes decreased the 
Ca2+ transfer from ER to mitochondria through IP3R under normoxic conditions. 
During hypoxia-reoxygenation (HR), the interaction between CypD and the IP3R1 
Ca2+ channeling complex increased concomitantly with mitochondrial Ca2+ content. 
Inhibition of either CypD, IP3R1 or Grp75 decreased protein interaction within 
the complex, attenuated mitochondrial Ca2+ overload and protected cells from 
HR. Pharmacological inhibition of CypD provided similar effect in adult mice 
cardiomyocytes. Noteworthy, disruption of ER-mitochondria interaction via the 
down-regulation of Mfn2 similarly reduced the interaction between CypD and 
the IP3R1 complex and protected against HR injury.
Conclusions: Our data point to a new role of CypD at the ER-mitochondria 
interface and suggest that decreasing ER-mitochondria interaction at reperfusion 
can protect cardiomyocytes against lethal reperfusion injury through the reduction of 
mitochondrial Ca2+ overload via the CypD/VDAC1/Grp75/IP3R1 complex.
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Depressing mitochondria-reticulum interaction protects cardiomyocytes from 
lethal hypoxia-reoxygenation injury
Mélanie Paillard (1), Emily Tubbs (2), Pierre-Alain Thiebaut (1), Ludovic 
Gomez (1), Jérémy Fauconnier (3), Claire Crola Da Silva (1), Geoffrey Teixeira (4), 
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Jennifer Rieusset (2), Michel Ovize (1) 
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Background: Under physiological conditions, Ca2+ transfer from the endoplasmic 
reticulum (ER) to mitochondria occurs at contact points between the two organelles, 
and involves the VDAC1/Grp75/IP3R1 complex. Accumulation of Ca2+ into the 
mitochondrial matrix may activate the mitochondrial chaperone cyclophilin D 
(CypD) and trigger permeability transition pore (PTP) opening, whose role in 
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Figure – Abstract 293 – PC effect on early and late MVO
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Decreased plasmatic level of asymmetric dimethylarginine in the culprit 
artery after acute myocardial infarction
Karim Stamboul (1), Julie Lorin (2), Jean Claude Guilland (1), Marianne Zeller (1), 
Luc Rochette (1), Luc Lorgis (1), Yves Cottin (1), Catherine Vergely (2) 
(1) Inserm UMR 866, LPPCM, Dijon cedex, France – (2) Inserm UMR866, 
LPPCM, Dijon, France
Introduction: Asymmetric dimethylarginine (ADMA) is an endogenous 
L-arginine derived arising from degradation of proteins containing methylated 
residues. ADMA is a competitive inhibitor of endothelial NO synthase (eNOS) 
leading to a decreased NO bioavailability, and increased oxidative stress, thus resulting 
in endothelial dysfunction. Recent data suggest its implication in cardiovascular 
pathologies and its association with a worse prognosis after ST elevation myocardial 
infarction (STEMI). The aim of our study was to assess the potential difference 
between systemic and local plasmatic levels of ADMA, and also between culprit 
and non culprit artery after STEMI. 
Methods: Blood samples from 38 consecutive patients hospitalized <24 hours 
after symptom onset for STEMI and admitted to the coronary care unit of from 
Dijon University Hospital were taken from the peripheral vein, the culprit artery by 
thrombo-aspiration device and the non culprit artery. Serum levels of L-arginine, 
ADMA and SDMA were determined using high-performance liquid chromatography. 
Results: Patients were pretty young (55 (47-64)), most were men (33 (72.8%)), most 
were smokers (31(81.6%)), and more than 13% arrived with a Killip score >1. Inter-ventricular 
anterior (IVA) artery was the culprit artery in 21 patients (55.3%), and the median of left 
ventricular ejection fraction was 55% (45-60). ADMA plasma levels in the culprit and non 
culprit artery were signifi cantly lower than ADMA plasma level in the vein (0.34±0.08 and 
0.37±0.09 vs 0.43±0.11; p<0.05). Thus, there was a trend for a lower ADMA plasma level 
in the culprit artery than in the non culprit artery (p=0.071). 
Conclusion: Our prospective study showed for the fi rst time in STEMI patients 
that there is a difference between local and systemic levels of ADMA and thus there is a 
trend for o decrease of the plasmatic level of ADMA at the culprit lesion site. Modulation 
of nitric and oxidative stress at the culprit lesion site could explain these differences.
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Hypoxia inducible factor and remote ischemic conditioning
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Background: Remote ischemic preconditioning (RIPC) provides strong 
cardioprotection against ischemia/reperfusion (I/R) injury. However, its molecular 
mechanisms remain unknown. Hypoxia Inducible Factor (HIF) is a transcription 
factor which plays a key role in the cellular adaptation to hypoxia. We aimed to test 
whether HIF would be involved in RIPC-induced cardioprotection.
Methods: Male Sprague Dawley rats were subjected to 40 min of myocardial 
ischemia followed by 2h of reperfusion (control group). RIPC with 4 cycle of limb I/R 
(5min each) was applied before myocardial ischemia (RIPC group). The role of HIF 
in RIPC was investigated using cadmium chloride (CdCl2), a HIF inhibitor (Cd RIPC 
group). In the second part of the study, HIF+/+ and HIF±genetically modifi ed mice were 
subjected to the same RIPC protocol. After the RIPC, homozygous and heterozygous 
mice underwent 30 min of myocardial ischemia followed by 2h of reperfusion.
Results: RIPC induced a robust activation of HIF in rat limbs. This activation was 
abolished by CdCl2 treatment. RIPC signifi cantly attenuated infarct size compared to 
control. Despite the inhibition of HIF, the cardioprotective effect of RIPC was preserved 
in Cd RIPC group. In the same way, RIPC induced a signifi cant cardioprotection in 
both HIF+/+ and HIF±mice.
Conclusion: Taken together, these results indicate that HIF is not involved in 
the mechanisms of RIPC-induced cardioprotection.
